A new review in Nature Mental Health strengthens the case that the gut microbiome directly shapes brain chemistry, stress responses,…
Browsing: Clinical Updates
OncoDaily GI spotlights the innovations transforming gastrointestinal oncology — from precision biomarkers to advances in equitable cancer care. The second…
The FDA has requested the withdrawal of obeticholic acid (Ocaliva), used to treat primary biliary cholangitis (PBC). Manufacturer Intercept Pharmaceuticals…
A new colonoscopy simulator from RZero Inc. (Mikoto™) is showing promise in training future endoscopists. Validated against the UK’s National…
A large Dutch study of over 239,000 individuals in a colorectal cancer (CRC) screening program found that endoscopist performance—measured by…
The third quarter of 2025 delivered key regulatory approvals, fresh clinical trial data, and important updates in GI care:
New research presented at DDW 2025 suggests that biomarker-guided therapy could help predict which IBD patients will respond best to…
A major UK trial is testing whether computer-assisted detection (CADe) truly transforms colonoscopy outcomes in everyday practice. Interim results from…
The FDA has approved guselkumab (Tremfya, J&J) as the first IL-23 inhibitor available in both subcutaneous (SC) and IV induction…
GI care is undergoing a quiet revolution. Once dismissed as psychosomatic, conditions like IBS and SIBO are now being reframed…